Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure
Open Access
Abstract
No abstract availableKeywords
Funding Information
- NIHR Bristol Biomedical Research Centre
- British Heart Foundation
- Riksförbundet HjärtLung
- Medical Research Council
- University College London Hospitals Biomedical Research Centre
- Stiftelsen för Strategisk Forskning
- Knut och Alice Wallenbergs Stiftelse
- Canada Research Chairs
- U.S. Food and Drug Administration
- Vetenskapsrådet
- Health Data Research UK
- European Research Council
This publication has 54 references indexed in Scilit:
- Estimating Causal Effects on a Disease Progression Trait Using Bivariate Mendelian RandomisationGenetic Epidemiology, 2024
- Intentional Weight Loss in Overweight and Obese Patients with Heart Failure: A Systematic ReviewEuropean Journal of Heart Failure, 2024
- Identification of Heart Failure Hospitalization from NHS Digital Data: Comparison with Expert AdjudicationESC Heart Failure, 2024
- Adjusting for collider bias in genetic association studies using instrumental variable methodsGenetic Epidemiology, 2022
- The Genomics of Heart Failure: Design and Rationale of the HERMES ConsortiumESC Heart Failure, 2021
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 DiabetesJAMA Cardiology, 2021
- Obesity Paradox in Heart Failure: A Heavy MatterESC Heart Failure, 2016
- Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled TrialEuropean Journal of Heart Failure, 2016
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection FractionJAMA, 2016
- Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk ResearchJAMA, 2011